-
Document de presse | 2022.01.11
Anne-Lise Mamessier Giraud appointed Director of the Hearing Institute, an Institut Pasteur Center
Professor Anne-Lise Mamessier Giraud has been appointed as Director of the Hearing Institute, an Institut Pasteur center. She took up office on January 1, 2022 and succeeds Professor Christine Petit in the role.Anne-Lise Mamessier Giraud has been appointed as Director of the Hearing Institute, an Institut Pasteur center, for an initial five-year term, from January 1, 2022 to December 31, 2026....
-
Document de presse | 2022.01.24
Pierre Buffet appointed as Medical Director of the Institut Pasteur
Professor Pierre Buffet has been appointed as Medical Director of the Institut Pasteur. Pierre Buffet took up his post on January 3, 2022 within the Institut Pasteur's Department of Scientific Affairs. Professor Pierre Buffet has been appointed as Medical Director within the Institut Pasteur's Department of Scientific Affairs, led by Senior Executive Scientific Vice-President Christophe d'...
-
Document de presse | 2022.04.13
Colon cancer: how mutation of the APC gene disrupts lymphocyte migration
In patients with familial adenomatous polyposis, a genetic disease predisposing to colon cancer, mutations of the APC gene induce the formation of intestinal polyps, but also reduce immune system activity. In a new study, researchers from the Institut Pasteur, INSERM(1) and Université Paris Cité describe the mechanisms that modify the structure of T lymphocytes and hinder their migration towards...
-
News | 2022.12.13
ERC Starting Grants: three scientists working at the Institut Pasteur among the successful candidates
On November 22, 2022, the European Research Council unveiled the list of recipients of ERC Starting Grants, a funding instrument aimed at early career scientists. The 408 laureates include three scientists working at the Institut Pasteur.
-
Document de presse | 2023.03.31
The Institut Pasteur and the University of São Paulo sign articles of association to establish the Institut Pasteur in São Paulo
On Friday March 31st, 2023 at a ceremony in Paris, the Institut Pasteur President, Professor Stewart Cole, and the University of São Paulo (USP) Rector, Carlos Gilberto Carlotti Junior, signed articles of association for the Institut Pasteur in São Paulo, a private non-profit organization under Brazilian law. The mission of the institute, an associate member of the Pasteur Network, is to conduct...
-
Document de presse | 2023.07.11
A global overview of antibiotic resistance determinants
To understand the main determinants behind worldwide antibiotic resistance dynamics, scientists from the Institut Pasteur, Inserm, Université de Versailles Saint-Quentin-en-Yvelines and Université Paris-Saclay developed a statistical model based on a large-scale spatial-temporal analysis. Using the ATLAS antimicrobial resistance surveillance database, the model revealed significant differences in...
-
Document de presse | 2023.07.20
HIV: 20 months' remission after a bone marrow transplant with no protective mutation – the Geneva patient
In February 2023, the IciStem consortium, which includes Asier Sáez-Cirión's team at the Institut Pasteur, published details in Nature Medicine of a third case of HIV remission after a bone marrow transplant, involving the Düsseldorf patient. A total of 5 individuals (the Berlin, London, Düsseldorf, New York and City of Hope patients) are now considered as having probably been cured of HIV...
-
Document de presse | 2024.02.14
Smoking has long-term effects on the immune system
Like other factors such as age, sex and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. For...
-
News | 2022.10.17
Antifungal therapy: Csa6 protein, a potential target for treatment development
A team of scientists has revealed a gene (CSA6) that regulates genome stability in Candida albicans and other related fungi. The protein produced by this gene, Csa6, therefore represents a potential target for antifungal therapy, at a time when there is an urgent need for the development of novel treatments for fungal infections.
-
Document de presse | 2024.09.03
First sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
Case of Geneva patient presented in the prestigious scientific journal Nature Medicine.A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. Romuald, the Geneva...